SciELO - Scientific Electronic Library Online

 
vol.36 issue1Desarrollo de la formulación de cefalexina 250 mg granulado para suspensión oral author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Farmacia

On-line version ISSN 1561-2988

Abstract

GONZALEZ CHAVEZ, Lissette et al. Diseño y evaluación de nuevas formulaciones de tabletas de acetato de cortisona (25 mg). Rev Cubana Farm [online]. 2002, vol.36, n.1, pp. 7-14. ISSN 1561-2988.

Three different formulations of cortisone acetate tablets (25 mg) were produced at laboratory scale aimed at obtaining a formulation that fulfills the parameters established by the British Pharmacopoeia (2000), specifically the dissolution parameter that is not fulfilled by the current formulation. In the 3 studied formulations the agglutinant solution of the present formulation (gelatin-starch) was substituted by polyvynilpyrrolidone in alcoholic solution and extragranular disintegrator (acdisol) was added, among other variations. The tablets were analyzed taking into account the technological and analytical characteristics according to the quality specifications of the official pharmacopoeias. The content uniformity trial was also carried out by using a spectrophotometric method previously validated. The physical and chemical stability of the 3 assayed formulations was studied during 3 years. All the formulations met the quality parameters established when they were newly manufactured and during the studied period of useful life, which supports the feasibility for their production at a pilot scale.

Keywords : CHEMISTRY, PHARMACEUTICAL; QUALITY CONTROL; DRUG STABILITY; CORTISONE [administration & dosage]; CORTISONE [analysis]; ADRENAL CORTEX HORMONES [analysis]; TABLETS [analysis]; TECHNOLOGY, PHARMACEUTICAL..

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License